Literature DB >> 22522504

Testosterone and cardiovascular disease in men.

Paul D Morris1, Kevin S Channer.   

Abstract

Despite regional variations in the prevalence of coronary artery disease (CAD), men are consistently more at risk of developing and dying from CAD than women, and the gender-specific effects of sex hormones are implicated in this inequality. This 'Perspectives' article reviews the current evidence regarding the cardiovascular effects of testosterone in men including an examination of the age-related decline in testosterone, the relationship between testosterone levels and coronary disease, coronary risk factors and mortality. We also review the vaso-active effects of testosterone, and discuss how these have been used in men with heart failure and angina. We discuss the 'cause' versus 'effect' controversy, regarding low testosterone levels in men with coronary heart disease, as well as concerns over the use of testosterone replacement therapy in middle aged and elderly men. The article concludes with a discussion regarding the future direction for work in this interesting area, including the relative merits of screening for, and treating hypogonadism with testosterone replacement therapy in men with heart disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22522504      PMCID: PMC3720171          DOI: 10.1038/aja.2012.21

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  93 in total

1.  Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses.

Authors:  Anders Bojesen; Svend Juul; Niels H Birkebaek; Claus H Gravholt
Journal:  J Clin Endocrinol Metab       Date:  2006-01-04       Impact factor: 5.958

2.  Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

Authors:  Varant Kupelian; Stephanie T Page; Andre B Araujo; Thomas G Travison; William J Bremner; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2006-01-04       Impact factor: 5.958

3.  Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits.

Authors:  P Alexandersen; J Haarbo; I Byrjalsen; H Lawaetz; C Christiansen
Journal:  Circ Res       Date:  1999-04-16       Impact factor: 17.367

4.  Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial.

Authors:  Chris J Malkin; Peter J Pugh; John N West; Edwin J R van Beek; T Hugh Jones; Kevin S Channer
Journal:  Eur Heart J       Date:  2005-08-10       Impact factor: 29.983

5.  Acute anti-ischemic effect of testosterone in men with coronary artery disease.

Authors:  G M Rosano; F Leonardo; P Pagnotta; F Pelliccia; G Panina; E Cerquetani; P L della Monica; B Bonfigli; M Volpe; S L Chierchia
Journal:  Circulation       Date:  1999-04-06       Impact factor: 29.690

6.  Androgen treatment of abdominally obese men.

Authors:  P Mårin; S Holmäng; C Gustafsson; L Jönsson; H Kvist; A Elander; J Eldh; L Sjöström; G Holm; P Björntorp
Journal:  Obes Res       Date:  1993-07

7.  Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease.

Authors:  C M Webb; J G McNeill; C S Hayward; D de Zeigler; P Collins
Journal:  Circulation       Date:  1999-10-19       Impact factor: 29.690

8.  Effect of acute testosterone on myocardial ischemia in men with coronary artery disease.

Authors:  C M Webb; D L Adamson; D de Zeigler; P Collins
Journal:  Am J Cardiol       Date:  1999-02-01       Impact factor: 2.778

9.  Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit.

Authors:  Molly M Shores; Victoria M Moceri; David A Gruenewald; Kayla I Brodkin; Alvin M Matsumoto; Daniel R Kivlahan
Journal:  J Am Geriatr Soc       Date:  2004-12       Impact factor: 5.562

10.  Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.

Authors:  D Tripathy; P Shah; R Lakshmy; K S Reddy
Journal:  Horm Metab Res       Date:  1998-10       Impact factor: 2.936

View more
  22 in total

Review 1.  Effects of opium consumption on cardiometabolic diseases.

Authors:  Farzad Masoudkabir; Nizal Sarrafzadegan; Mark J Eisenberg
Journal:  Nat Rev Cardiol       Date:  2013-10-22       Impact factor: 32.419

2.  Lean tissue mass and energy expenditure are retained in hypogonadal men with spinal cord injury after discontinuation of testosterone replacement therapy.

Authors:  William A Bauman; Michael F La Fountaine; Christopher M Cirnigliaro; Steven C Kirshblum; Ann M Spungen
Journal:  J Spinal Cord Med       Date:  2014-06-26       Impact factor: 1.985

Review 3.  Leydig cell stem cells: Identification, proliferation and differentiation.

Authors:  Haolin Chen; Yiyan Wang; Renshan Ge; Barry R Zirkin
Journal:  Mol Cell Endocrinol       Date:  2016-10-12       Impact factor: 4.102

4.  Transplantation of alginate-encapsulated seminiferous tubules and interstitial tissue into adult rats: Leydig stem cell differentiation in vivo?

Authors:  Haolin Chen; Shiying Jin; Shengsong Huang; Janet Folmer; June Liu; Renshan Ge; Barry R Zirkin
Journal:  Mol Cell Endocrinol       Date:  2016-08-31       Impact factor: 4.102

5.  Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study.

Authors:  Guneet K Jasuja; Shalender Bhasin; Joel I Reisman; Joseph T Hanlon; Donald R Miller; Anthony P Morreale; Leonard M Pogach; Francesca E Cunningham; Angela Park; Dan R Berlowitz; Adam J Rose
Journal:  J Gen Intern Med       Date:  2016-12-19       Impact factor: 5.128

Review 6.  Differentiation of mesenchymal stem cells into gonad and adrenal steroidogenic cells.

Authors:  Takashi Yazawa; Yoshitaka Imamichi; Kaoru Miyamoto; Akihiro Umezawa; Takanobu Taniguchi
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

7.  Testosterone is negatively associated with the severity of coronary atherosclerosis in men.

Authors:  Li Li; Chang-Yan Guo; En-Zhi Jia; Tie-Bing Zhu; Lian-Sheng Wang; Ke-Jiang Cao; Wen-Zhu Ma; Zhi-Jian Yang
Journal:  Asian J Androl       Date:  2012-10-08       Impact factor: 3.285

Review 8.  The practical management of testosterone deficiency in men.

Authors:  Antonio Aversa; Abraham Morgentaler
Journal:  Nat Rev Urol       Date:  2015-10-13       Impact factor: 14.432

Review 9.  Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients.

Authors:  Sakthivel Muniyan; Lei Xi; Kaustubh Datta; Anindita Das; Benjamin A Teply; Surinder K Batra; Rakesh C Kukreja
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-06-11       Impact factor: 10.680

Review 10.  Advances in stem cell research for the treatment of primary hypogonadism.

Authors:  Lu Li; Vassilios Papadopoulos
Journal:  Nat Rev Urol       Date:  2021-06-29       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.